GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS) » Definitions » Investments And Advances

Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Investments And Advances : $75.72 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ginkgo Bioworks Holdings Investments And Advances?

Ginkgo Bioworks Holdings's Investments And Advances for the quarter that ended in Mar. 2024 was $75.72 Mil.

Ginkgo Bioworks Holdings's quarterly Investments And Advances declined from Sep. 2023 ($85.61 Mil) to Dec. 2023 ($77.91 Mil) and declined from Dec. 2023 ($77.91 Mil) to Mar. 2024 ($75.72 Mil).

Ginkgo Bioworks Holdings's annual Investments And Advances declined from Dec. 2021 ($115.23 Mil) to Dec. 2022 ($111.79 Mil) and declined from Dec. 2022 ($111.79 Mil) to Dec. 2023 ($77.91 Mil).


Ginkgo Bioworks Holdings Investments And Advances Historical Data

The historical data trend for Ginkgo Bioworks Holdings's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ginkgo Bioworks Holdings Investments And Advances Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
- 103.12 115.23 111.79 77.91

Ginkgo Bioworks Holdings Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.33 119.97 85.61 77.91 75.72

Ginkgo Bioworks Holdings Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Ginkgo Bioworks Holdings (Ginkgo Bioworks Holdings) Business Description

Traded in Other Exchanges
Address
27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Foundry and Biosecurity. The Biosecurity segment generates the majority of revenue.